Skip to content

Radiofrequency Catheter Ablation for Chronic Atrial Fibrillation

Randomized Comparison of Radiofrequency Catheter Ablation vs. Antiarrhythmic Therapy With Amiodarone for Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00272636
Enrollment
140
Registered
2006-01-06
Start date
2002-11-30
Completion date
2005-02-28
Last updated
2015-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

atrial fibrillation, catheter ablation, amiodarone, cardioversion

Brief summary

The purpose of this study is to determine the long-term efficacy of radiofrequency catheter ablation in patients with chronic atrial fibrillation.

Interventions

PROCEDURERadiofrequency catheter ablation
DRUGAmiodarone and cardioversion

Sponsors

San Raffaele University Hospital, Italy
CollaboratorOTHER
University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Chronic atrial fibrillation

Exclusion criteria

* Left atrial diameter \>55 mm * Left ventricular ejection fraction \<0.30 * Contraindication to amiodarone therapy or anticoagulation with warfarin * Presence of a mechanical prosthetic valve * History of a cerebrovascular accident * Presence of left atrial thrombus on TEE * Prior attempt at catheter or surgical ablation for atrial fibrillation

Design outcomes

Primary

MeasureTime frame
Freedom from atrial fibrillation and atrial flutter in the absence of antiarrhythmic drug therapy at 1 year.

Secondary

MeasureTime frame
incidence of complications
changes in left atrial diameter
changes in left ventricular ejection fraction
changes in symptom severity

Countries

Italy, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026